Yahoo Finance29d
Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus
Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024--(BUSINESS WIRE)--Merck Animal Health ...
Investing29d
Merck launches new feline leukemia vaccine NOBIVAC NXT FeLV
is set to be available in veterinary clinics and hospitals across the United States this fall. NOBIVAC NXT FeLV is the first FeLV vaccine leveraging Merck's RNA-particle platform, similar to the ...
pharmaphorum12d
Changing Faces – Board appointments September 2024
MERGE announces new Chair. MERGE, a Chicago-based integrated technology and marketing services provider, has a new board ...
BioSpace28d
Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus
The vaccine is expected to be available at veterinary clinics and hospitals nationwide this fall. NOBIVAC NXT FeLV is the first and only feline leukemia virus vaccine built on Merck Animal Health’s ...
The Huntsville Item29d
Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the expansion of the newly ...
dvm36029d
New vaccine protects against feline leukemia virus
1 “Merck Animal Health and our NOBIVAC brand have a rich history in vaccine innovation, and we’re continuing to prove our dedication to ensuring there are safe and effective treatment options for ...